Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-01-22
2008-09-02
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S492000
Reexamination Certificate
active
07419976
ABSTRACT:
Pharmaceutically active diazepanes, e.g. useful for treating disorders or diseases mediated by LFA-1/ICAM-1, LFA-1/ICAM-2, LFA-1/ICAM-3 or LFA-1/JAM-1 interactions.
REFERENCES:
patent: 6399599 (2002-06-01), Albert et al.
patent: 01/27102 (2001-04-01), None
patent: 02/28842 (2002-04-01), None
patent: 02/059114 (2002-08-01), None
Sompong Wattanasin, “1-4-Diazepane-2-ones as novel inhibitors of LFA-1”, Bioorganic and Medicinal Chemistry Letters, vol. 13, No. 3, pp. 499-502 (2002).
Meingassner Josef G
Oberhauser Berndt
Kifle Bruck
Novartis AG
LandOfFree
Diazepanes derivatives useful as IFA inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diazepanes derivatives useful as IFA inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazepanes derivatives useful as IFA inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3990909